Patient-Centered Decision-Making in Cold Agglutinin Disease

Prev
 1 / 18 
Next
Prev
 1 / 18 
Next

Learning objectives

After completing this quiz, the learner should be able to:

  • explain why patient-centered decision-making is essential in CAD
  • recognize that many CAD decisions involve trade-offs rather than right answers
  • understand how symptom burden and hemoglobin can diverge
  • incorporate patient risk tolerance and life context into treatment strategy
  • explain treatment tempo clearly as part of informed consent
  • manage disagreement, uncertainty, and treatment refusal without abandoning clinical rigor

Why is patient-centered decision-making especially important in cold agglutinin disease?

a
CAD has no effective therapies
Effective therapies exist; the challenge is choosing among them.
b
Laboratory values are often unreliable
Labs are reliable but incomplete.
c
Multiple reasonable treatment paths exist with different trade-offs
CAD management often involves balancing speed, durability, burden, and risk.
d
Guidelines do not address CAD
Guidelines exist but cannot resolve value-based trade-offs.

Which statement best captures patient-centered care in CAD?

a
Patient preferences replace clinical judgment
Clinical rigor remains essential.
b
Evidence is applied in a way that fits the person living with the disease
Patient-centered care integrates evidence with lived experience.
c
Treatment decisions should reflect patient preferences above clinical evidence
This represents abdication, not partnership.
d
Shared decision-making is only needed when evidence is weak
Even strong evidence requires contextual application.

From a patient’s perspective, CAD decisions are most often framed as:

a
“Which drug has the best response rate?”
Patients rarely think in pharmacologic terms.
b
What do guidelines recommend?”
Guidelines do not answer personal trade-offs.
c
“How will this choice affect my daily life and future plans?”
Patients weigh treatment against work, travel, caregiving, and identity.
d
“How soon will my LDH normalize?”
Laboratory normalization is usually not the primary concern.

Why can treating CAD based solely on hemoglobin level be misleading?

a
Hemoglobin measurement is inaccurate in CAD
Hemoglobin measurement is accurate
b
Symptoms may correlate poorly with hemoglobin
Fatigue, pain, and cold intolerance may dominate despite “acceptable” levels.
c
Anemia is usually mild
Severity varies widely.
d
Hemoglobin normalizes spontaneously
Spontaneous normalization is uncommon.

Which statement best reflects appropriate handling of patient risk tolerance?

a
Risk tolerance should align with clinician comfort
Clinician comfort is not the metric.
b
Lower-risk patients should always choose conservative therapy
Risk tolerance is personal, not algorithmic.
c
There is a single correct risk tolerance once patients are informed
Informed patients may still choose differently.
d
Different patients may reasonably make different choices
Informed variation is expected and appropriate.

Why is explaining treatment tempo essential in CAD care?

a
To align expectations with how therapies actually work over time
Misunderstanding tempo drives frustration and mistrust.
b
To ensure patients accept clinician recommendations
Consent is not persuasion.
c
To justify delayed response as success
Delayed response is not inherently success.
d
To discourage patients from reconsidering decisions
Reconsideration is appropriate and expected.

Which scenario best reflects expert patient-centered reassessment?

a
Changing therapy only after laboratory failure
Labs alone are insufficient.
b
Continuing therapy despite rising burden because it once worked
This risks therapeutic inertia.
c
Revisiting goals when life context or symptom tolerance changes
Goals evolve, even when biology does not.
d
Avoiding discussion of uncertainty to reduce anxiety
Avoidance increases harm.

When a patient declines recommended disease-directed therapy, which response best reflects patient-centered care?

a
Document refusal and discharge from follow-up
Abandonment is not respect for autonomy.
b
Reiterate risks until the patient agrees
Coercion erodes trust.
c
Optimize supportive care and maintain engagement
Vigilance and support continue even when therapy is declined.
d
Defer all future clinical recommendations
Clinical responsibility remains.

When discussing treatment options with uncertain outcomes, which approach best supports patient decision-making?

a
Hemoglobin fluctuation within the patient’s usual range
False precision can mislead.
b
Minimize discussion of uncertainty to avoid anxiety
Avoidance undermines trust.
c
Acknowledge uncertainty honestly while framing it as navigable together
Honest, shared uncertainty supports agency and partnership.
d
Defer discussion until outcomes are more predictable
Deferral delays meaningful engagement.

Which situation represents an appropriate limit on patient preference in CAD?

a
A patient prefers clone-directed therapy over complement inhibition
Reasonable trade-off.
b
A patient prioritizes treatment-free intervals over rapid control
Reasonable value judgment.
c
A patient wants to delay treatment to complete a work project
Reasonable contextual prioritization.
d
A patient requests stopping complement inhibition during active hemolysis without alternative management
This carries unacceptable immediate risk and requires clinician intervention.

Why is communication itself considered a therapeutic intervention in CAD?

a
It replaces pharmacologic treatment
Communication complements, not replaces, therapy.
b
It shapes how patients experience uncertainty and fluctuation
Framing influences anxiety, trust, and symptom burden.
c
It reduces the need for monitoring
Monitoring remains necessary.
d
It ensures patients follow recommendations
Adherence is not the primary goal of communication.

Sort each factor by its primary frame

Markers of hemolysis
Treatment burden
Clonal activity
Cold-avoidance lifestyle constraints
Transfusion frequency
Impact on work, travel, and caregiving
Hemoglobin level
Fatigue and cold intolerance
Disease biology
Patient experience

Match each concept to its clinical implication:

Rapid control
Shared reassessment
Finite therapy
Prioritizes predictability and symptom relief
Accepts delayed benefit for potential remission
Normalizes course correction without blame
Correct! Sorry, Incorrect.

Closing Note

This quiz does not ask what to prescribe.
It asks how to practice.

Patient-centered decision-making in CAD is not softness,
it is precision applied to a human life.

Prev
 1 / 18 
Next